Beruflich Dokumente
Kultur Dokumente
July 2013
DISCLAIMER: This report has been generated in consonance with CNS and Lilly MDR-TB
Partnership, a Corporate Responsibility initiative of Eli Lilly and Co. (India) Pvt. Ltd. after a
survey and a detailed research to generate recommendations on Management of Drug
Resistant Tuberculosis across India. This report so generated focuses on best practices in
PMDT at selected sites in India. The recommendations and the information of the
infrastructure shall in no way be construed as promotion of specifically covered institutions.
This report shall in no way be considered a substitute to any personalized advice of Health
Care Providers on the disease state of an individual.
The interviews of Nurses, support staff or HCPs are only limited to suggestions and the best
practices of various institutes and hence in no way intended to harm image of any institution
that does not have practices that are alike. The expression of opinion or view point are
general in nature and any reference to any person, living or dead, is coincidental and with no
intent to harm any personal interest.
The report conceived after survey and research and public disclosure of the same has been
done based on the consent of respective stakeholders including but not limited to picture/
images of Patients, Nurses and HCPs.
This report has been generated in Public interest and for the wellbeing of the society.
After a whirlwind search for cure, found relief at PMDT site in Delhi 119
Blew up more than cost of MDR-TB treatment in private sector 120
Deserted by husband’s family, she needs an oxygen cylinder to 121
breathe
MDR-TB survivor also bravely battles against a rare genetic disease 123
We can stop TB: With a little bit of love and a pinch of will power 126
Annexure I Patients’ Charter for Tuberculosis Care 129
Annexure II What PMDT Guidelines say on infection control? 133
Annexure III What PMDT Guidelines say on counselling? 134
Annexure IV What PMDT Guidelines say on diagnostics and laboratory 135
services?
Annexure V What PMDT Guidelines say on treatment and care? 137
Annexure VI What PMDT Guidelines say on treatment outcome definitions? 139
Despite successes TB continues to remain one of the key public health priorities in
India. Drug-resistant TB is one of the concerns and India envisions providing universal
access to quality diagnostics and treatment services for all patients with drug-
resistant TB in next five years.
CNS with support from Lilly MDR TB Partnership in India embarked upon this mission
to document best practices and lessons learnt from some select sites of Programmatic
Management of Drug-resistant Tuberculosis (PMDT) in India. We conducted close to
200 key informant interviews with key stakeholders – cured patients of multidrug-
resistant TB (MDR-TB), MDR-TB patients currently on treatment and their family
members, extensively drug-resistant TB (XDR-TB) patients, nurses, doctors, laboratory
technicians, microbiologists, PMDT site nodal officers, state and district TB officers,
among other stakeholders. We took photographs too of PMDT related services. All
interviews and photographs were taken after due consent in English or local
vernacular languages.
CNS analyzed the evidence thus generated and is coming up with specific
recommendations to help achieve universal access to quality diagnostics and
treatment in PMDT across the country. CNS has produced five-part series of “Best
Practices in PMDT in India” on following specific themes:
Infection control
Counselling
Diagnostics and laboratory services
Treatment and care
Personal stories of people with drug-resistant TB and
MDR-TB survivors
We are very grateful to the (current and cured) patients of drug-resistant TB, their
family members, care providers and other key stakeholders who consented to be
interviewed and helped us learn vital lessons. Our sincere thanks also to: Dr KS
Sachdeva, Central TB Division; Dr Jayant Banavaliker, former Director, RBIPMT; and
Sunita Prasad, Lilly MDR TB Partnership India for their constant support and guidance.
METHODOLOGY
With informal discussions with Dr KS Sachdeva, Additional Director General, Central
TB Division, and Ms Sunita Prasad, Lilly MDR TB Partnership and PPP Focal Point of
Partnership for TB Care and Control in India, CNS selected PMDT sites that had
significant number of people seeking treatment and care for drug-resistant TB, and
were functional since past few years (except one new PMDT site that was a year old).
We also selected national reference laboratories (NRLs) and state’s intermediate
reference laboratories (IRLs) along with a private diagnostic laboratory of repute.
Innovative approaches such as home-based care models or other centres that were
doing inspiring work to enhance positive outcomes of PMDT sites were also included.
We covered 14 sites in 6 cities (see table below) during January – March 2013 and
conducted over 200 key informant interviews. Apart from these sites, we also
interviewed cured MDR-TB patients in Delhi and Gujarat. These interviews were
transcribed, translated and qualitative data analysed to produce a 5-part series on
infection control, counselling, diagnostics and laboratory services, treatment and
personal testimonies of MDR-TB and XDR-TB patients (including cured patients).
All photographs and key informant interviews were conducted after seeking due
consent. Consent forms were available in English, Gujarati, Bengali and Hindi. We
credit CNS team members who worked hard on this initiative: Shobha Shukla (editor),
Mukta Srivastava, Rahul Dwivedi and Bobby Ramakant.
WAY FORWARD
We aim to disseminate these 5-part series of advocacy documents in a media workshop
in Delhi in June 2013, send them to the key people at all the sites we covered across the
country and last but not the least to Central TB Division requesting them to consider
incorporating the recommendations on infection control, counselling, diagnostics and
laboratory services and treatment and care services in PMDT in India. Some of the
recommendations are also for strengthening or establishing linkages with other
programmes or departments of the government and we will aim to deliver these to
appropriate agencies. We also aim to exhibit the photo essay at different opportunities
and also share it with the sites for non-commercial use such as patient or community
education. We believe that these 5-part series of advocacy documents and photo essay
might also be of use to new and upcoming PMDT sites, private centres or other
supporting initiatives by NGOs and PPP approaches. We will make these materials available
for them as well.
Sputum collection area was also away from the main thoroughfares, and person giving
sputum was supposed to give sputum
sample in an open, empty, segregated
and cross-ventilated side corridor.
We found that the indoor ward for patients of drug-resistant TB was very well cross-
ventilated, with well-spaced beds, enough natural sunlight, and clean floors. This
ward was away from other areas of the building and wash rooms were separated by a
corridor.
DR AMAR SHAH, WHO consultant for RNTCP for the state of Gujarat
(at BJMC, Ahmedabad) said: “For infection control we follow
certain measures at all our drug-resistant TB sites. There is
maximum ventilation in the wards. We make sure to have area
equivalent to at least 20% of the floor area, to have open air space
and cross-ventilation. Our healthcare staff monitors proper and
regular air exchange. Each patient is provided with sputum cups
and surgical masks.”
A patient re-admitted in the MDR-TB ward due to some breathing problem said that
she follows all the infection control methods explained by the doctors/nurses to be
practiced at home.
DR VR PRADHAN, Superintendent, KS
Roy Hospital, told us that, “Infection control is a very important part of controlling
the spread of the disease and we strictly follow all the air borne infection control
Lok Nayak
Hospital, Delhi
When we went to the
Hospital in February 2013,
the indoor wards had been
temporarily closed for
renovation work. So patients
who needed to be admitted
were being accommodated
in Rajan Babu Institute of
Pulmonary Medicine and
Tuberculosis. We found that
the OPD was located in a
very big hall with separate
large and open cubicles for
When I sought permission to interview some patient in the model ward, I had to wear
an N95 mask before entering the negative pressure special wards.
The hospital also has the normal 40 bedded ward for patients of drug
resistant TB where all infection control measures were found to be in
place—sunlit ward, well- spaced beds, proper cross ventilation, exhaust
fans, sputum disposal cups with each patient, among others. All the
patients were wearing masks.
The sputum sample collection room was away from the OPD and wards but located in
a naturally ventilated open area. A chart giving clear instructions on AFB Smear
Staining was pinned on the wall of the room.
The RNTCP sanctioned the posts of counsellors in 2011. So now we have stopped
taking the help of NGOs in the area of counselling as it a part of the programme. Now
we have diverted their help to other areas like helping with TB programme among
prisoners. We have also started a programme where the counsellors are appointed for
TB patients in the prisons.
Face to face communication always proves to be successful. I even call the patients to
meet me, wherever mutually convenient (and not necessarily in a clinic setting), to
counsel them in case they do not want me to come to their house. My staff also
coordinates accordingly and counsels patients outside their homes if necessary.
I would like to recall one incident. I still remember my first patient of MDR-TB: Leela
Ben. She was a vegetable vendor. A private doctor had his clinic nearby and he really
helped and counselled her. The doctor went to his clinic every day, even on holidays,
to give the medicine to her. He was from private setup but he ensured patients
adhered to complete treatment and coordinated very well with us. I feel very
satisfied even if I am able to save one patient. All my past
patients still are in contact with me and we share a very good
relationship.”
We also give the phone numbers of all our healthcare providers to the patients. We
tell them that they are free to call anyone of us at any odd time and we will be there
Cyclocerine is the worst drug in terms of side-effects which gives rise to psychological
problems like suicidal tendency and acute depression. We have patients who have
tried to commit suicide. Other side effects like joint pain, nausea etc are minor ones.
With the help of Eli Lilly we have tried to rehabilitate patients by giving them cycles,
sewing machines, lorries to sell vegetables, etc.”
So counselling is important for two reasons- for adherence to treatment and for air
borne infection control.”
MDR-TB Patient:
“I am very happy here. The sisters (nurses) are doing much more than my family could
ever have done. All the responsibilities which should have been taken by my family
members are being taken by the sisters (nurses), caregivers and doctors of this
hospital. I am very grateful to all the hospital staff. We should believe the nurses and
doctors, and other healthcare givers, listen to them and follow what they tell about
what to do and what not to do and adhere to the treatment schedule. This is going to
benefit us after all.
“We cannot help the patient with any physical problems (arising
out of medication) as these problems are dealt by the doctors
and the nurses. But the counsellor can play a major role when
the patient undergoes mental problems and needs some social
support. The patients start from CAT-1 and then goes to CAT-2
and then to CAT-4. So, it is a long period that they have to
undergo treatment for MDR-TB. We come across many cases of
frustration because every time the patients are told that they
will get cured soon. Even in CAT-1 they are assured of the fact
that they will be cured. The same thing is conveyed in CAT-2
also although it may not happen and then it may lead to MDR-TB
and so, frustration occurs. So, we help these patients in such
cases. We give mental strength to the patient which is very important. There are
stigmas associated with the disease and we help patients to overcome them.
WOMEN AND TB
It is generally seen that if a woman is having TB then she is being looked after by her
parents, brother, sister or anyone but not in-laws or husband. I would also like to
WAY FORWARD
Usually there is a single counsellor for so many patients and the number is increasing
day by day. It is very difficult for one single counsellor to address problem of all
patients so it is very important that counselling should not be seen separate and it
should be integrated at all levels. We may start with the staff of the hospital as they
may also have misconceptions.”
Constant counselling at every centre will help. We also have counselling tools for all
healthcare staff - the medical officer at the peripheral unit, district TB officer, the
medical officer of the MDR-TB centre or wherever the patient comes and seeks help.
We all are being given training to give counselling at whatever level we are, apart
from the counsellors hired specifically for that purpose.
The RNTCP is now planning to have counsellors to counsel all the MDR-TB patients.
Under the RNTCP within about a year’s time we will have counsellors who would help
patients because that is very important. We have learnt from different programmes,
like the AIDS programme, that the role of counsellors is very important.
I know that there is a big load on doctors but that does not mean that they should not
attend to the patient properly. It is necessary to attend to the patient and counsel
him well. Health education and treatment literacy is important not only for the
medical staff but also for the patients. Patients have an important role to play in
successful completion of treatment. Counselling is also important to keep the morale
of the patient high.”
The first visit is very long when all the family history of disease as well as other
information is sought. We tell them about the side-effects that can occur and also ask
in detail if they are facing any of them. We have found that over 40% patients have
joint pains, 20% have nausea and vomiting, 15% suffer from anxiety. Besides these,
there are numerous other side effects, including weakness. The patients have the
The first visit is very long when all the family history of
disease as well as other information is sought. We tell
them about the side-effects that can occur and also ask in
detail if they are facing any of them. We have found that
over 40% patients have joint pains, 20% have nausea and
vomiting, 15% suffer from anxiety. Besides these, there
are numerous other side effects, including weakness.
The second phase of our project Some times their family members are
started in September 2012 in
which we have nearly 200 scared to take care of them for fear of
patients, and as some of them contracting the disease. So we counsel
complete their treatment we will them as well. We tell them about
take more patients. We have a
very good coordination with the infection control methods to be followed
government. This is all due to our at home to prevent spread of the
very dedicated team members who disease—cover the mouths of patients,
make a very good rapport with the
patients. Seeing our work, Dr cough hygiene, sputum disposal methods
Ashwani has given us some special (burying it or heating it on fire and then
cases to handle (patients who have disposing it). Taking care of the adverse
left treatment midway repeatedly
or those patients who are side effects of medicines plays a very big
addicted). role in restoring patients’ confidence
and ensuring treatment adherence. In
There are over 50 children
between 11 to 20 years of age who the 1st phase of our project we took 101
have MDR-TB and have had to patients of MDR-TB, out of which 69% are
leave their studies in between. cured and another 2% completed the
They have to be counselled in a
special way to be able to resume treatment (they have yet to get their
their studies.” final report). So 71% in all completed
their treatment
I feel very good to counsel them. I really listen to these persons and it feels good as
there is no one to listen to them. So I feel that I must talk to them patiently because
there is nowhere else these people can express their grief. I learnt from them that
whatever may be the problem we must have the courage to fight with it. So, I
consider myself very lucky to get a chance to work for them. Even if I get a call in the
night from any of them I am available. Right now I am making a movie on cured MDR-
TB and TB patients after interviewing them to spread the message that TB is curable.
It gives us a great feeling when some patient gets cured. We ask these cured patients
to tell other people that how they got well after bearing so many problems and how
our team members helped them in overcoming those problems.
We never wear masks when we talk to them so that they do not feel discriminated.
But we encourage them to use masks. Once we come out of one house we sanitise our
hands before visiting the next one.”
- The accuracy of
DST varies with
the drug tested.
Phenotypic DST is
very reliable for
isoniazid (H),
rifampicin (R),
and streptomycin
(S), and
somewhat less
reliable for other
drugs such as
ethambutol (E)
LIQUID - Mycobacterial culture and - Culture is much more - Specimens have
CULTURE identification of M. complex and expensive to be
(endorsed by tuberculosis provide a than microscopy to decontaminated
WHO in 2007) definitive diagnosis of TB, perform, requiring facilities prior to being
significantly increases the for media preparation, cultured to
- The number of cases found specimen processing, and prevent
turnaround (often byBest
30-50%), and can growth
Practices in PMDT of |organisms,
in India July 2013 overgrowth by
50
time for C-DST detect cases earlier (often specific laboratory other micro-
results by before they become equipment, skilled organisms. All
Liquid Culture infectious). Culture also laboratory technicians, and decontamination
(MGIT) is provides the necessary appropriate biosafety methods are to
around 42 days isolates for conventional conditions. some extent also
DST. harmful to
- BSL-III - Liquid systems are, mycobacteria,
laboratory - Liquid culture increases however, more prone to and culture is
required the case yield by 10% over contamination and the therefore not
solid media, and manipulation of large 100% sensitive.
- Phenotypic automated systems reduce volumes of infectious Good laboratory
method the diagnostic delay to material mandates practices
days rather than weeks. appropriate and adequate maintain a
biosafety measures. delicate balance
between yield of
- DST methods are suitable mycobacteria and
for use at central/national contamination by
reference laboratory level other micro-
only, given the need for organisms
appropriate laboratory
infrastructure (particularly - The accuracy of
biosafety) and the technical DST varies with
complexity of available the drug tested.
technologies/methods. Phenotypic DST is
very reliable for
isoniazid (H),
rifampicin (R),
and streptomycin
(S), and
somewhat less
reliable for other
drugs such as
ethambutol (E)
MOLECULAR - Genotypic methods have - LPAs do not eliminate the - LPAs are
LINE PROBE considerable advantages need for conventional suitable for
ASSAY (LPA) for scaling-up culture and DST capability. implementation
(was endorsed programmatic management Currently available LPAs at
by WHO in of drug-resistant and HIV- are registered for use only central/national
2008) associated TB, in particular on smear-positive sputum reference
with regard to speed, specimens laboratory level,
- The standardised testing, with potential for
turnaround potential for high - M. tuberculosis isolates decentralisation
time for C-DST throughput, and reduced grown from smear-negative to regional level if
results by LPA biosafety needs. specimens by conventional appropriate
is around 72 culture methods. infrastructure can
hours - Molecular/genotypic tests be ensured.
are much faster than
- BSL-II phenotypic tests, as - Conventional
laboratory molecular tests don’t culture (solid or
required require growth of the liquid) is still
- Molecular/
genotypic DST is
highly reliable for
rifampicin, but
has limited
sensitivity for
detection of
isoniazid
resistance
Xpert MTB/TIF - Genotypic methods have - Capacity of one device is - Xpert MTB/RIF
(endorsed by considerable advantages limited to 20 specimens per requires
WHO in for scaling-up day. Higher-volume settings uninterrupted and
December programmatic management may require more than one stable electrical
2010) of drug-resistant and HIV- device power supply and
associated TB, in particular yearly calibration
- The with regard to speed, - detects rifampicin of the cartridge
turnaround standardised testing, resistance only, although modules. The
time for C-DST potential for high clinical treatment can positive
results by throughput, and reduced commence as per predictive value
Xpert MTB/RIF biosafety needs. guidelines, culture DST of Xpert MTB/RIF
is around 2 needs to be done is low in settings
hours. - Xpert MTB/RIF detects where rifampicin
both TB and rifampicin resistance is rare
- BSL-II or BSL- resistance in a single test. and results need
III not required Rifampicin resistance is a to be confirmed
(suitable for good and reliable proxy for by phenotypic DST
all levels of MDR-TB in high burden or LPA.
laboratories) settings
- Conventional
- Genotypic - Molecular/genotypic tests culture (solid or
method are much faster than liquid) is required
phenotypic tests, as to monitor
molecular tests don’t treatment
require growth of the response (culture
organism, and M. conversion) of DR-
tuberculosis is notoriously TB patients.
slow growing.
- Xpert MTB/RIF is
highly reliable for
rifampicin
resistance only
Source: WHO Information Note on TB Diagnostics and Laboratory Services, online at:
http://www.who.int/tb/dots/lab.pdf
LPA
In a single strip of LPA we have the probe
for two main drugs, rifampicin and
isoniazid. If the patient is resistant to any
of these, the bacteria will wind on that
strip. So within 72 hours we can find out if
it is resistant or sensitive to these drugs. It
would take 3 months to get the same result by conventional culture methods.
At present molecular testing can be done only for two drugs: rifampicin and isoniazid.
For other drugs we do the conventional culture testing. But scientists are now working
to put another strip in LPA which has the probe
for another drug also.
XPERT MTB/RIF
It can detect resistance to rifampicin only. We
have had some cases where the patient is It would be
sensitive to rifampicin but resistant to isoniazid.
Such cases are more likely to come from rural best to test for
areas and especially in patients who are tobacco drug resistance
users. At some point of time they might have
been given streptomycin or isoniazid without at the start of
proper evaluation to cure their cough or cold. TB treatment
There is more mono-resistance in smokers,
‘gutkha’ eaters or users of other forms of itself…
tobacco. In Ghatampur village of Kanpur district,
we have a unit and this region has incidence of
There is also monitoring system to monitor the people who enter the laboratory; the
period for which they stayed in the laboratory; whether they wore apron and mask
and followed other protocols — all this is recorded with the help of
software.
EMERGENCY SHOWER
It can be used in case of emergency, in case if some reagent falls
down and casualty occurs during testing. Meanwhile the person
changes, takes a shower and informs via the intercom.
MOLECULAR FINGERPRINTING
There is a difference between relapse and reinfection.
This can be found by molecular fingerprinting. Suppose
in one strain I can see 4 fingerprints and after relapse
again I get the same number then it means that
patient has not been cured as yet. But if I get 2
fingerprints then it is a case of reinfection with
another strain of TB.
DNA SEQUENCER
The DNA sequencer gives confirmation of whether it is
a real MTB through sequencing. DNA sequencing is
done when the patient does not respond to treatment.
The reason for not responding can be either the person
is having drug-resistant TB or does not have TB at all
(it could be some other bacteria). In case if we do not
find the sequence for bacteria we tell the doctor. Such
cases are very rare—around 1%.
SPUTUM QUALITY
Quality of sputum sample is very important to get
a correct and quick diagnosis. After getting
35,000 sputum samples, between 2009 and 2012,
we rejected only 76 samples (as they were
samples with blood). The samples with blood do
not go through the LPA because the blood
contains PCR inhibitors. These samples would
have to go through the process of culture testing
which would take around one and a half months
to get the result. Otherwise if the samples were
good quality without blood, then LPA can test
and give the result in 2-3 days. So to avoid delay in diagnosis we counsel the patients
to give good quality sputum sample without blood and any food particle in it. We also
sensitize the healthcare providers to collect the best sputum sample. RNTCP
guidelines also recommend that patients should be told the correct method of giving
LIQUID CULTURE
We get the liquid media directly from
Becton, Dickinson and Company (BD) as
we have no guidelines in the RNTCP for
preparation of liquid media.
LPA
Gujarat is the pioneer of LPA. LPA takes 34 hours.
We have also devised methods for direct sputum microscopy and to receive samples
from the Central TB Division (CTD). So they are sending 2 samples. We do the direct
microscopy for the samples and if they are smear positive then we need to process a
single sample for higher tests such as LPA. But a year ago, we had to process both the
samples. So in this way we have reduced the workload as well as requirement of the
machinery.
PCR
We have the thermocycler for the amplification. In this instrument 10-12 samples can
be processed in on ego. GT Blot is used to get the amplified product.
During treatment, MDR-TB patients have to send their sputum samples 11 times for
follow up. On the basis of our data for the last 3 years (2009, 2010, 2011) of 7000-
8000 patients they have made the policy that for each patient only 1 sample needs to
be given every time (instead of two as was being done earlier). We are also doing
another operational research in which we process only one sample for all smear
negative patients. Before that we were taking 3 samples to diagnose TB. But
We collect the samples and slides from various places and then process them under
the direct microscopy under strict quality control just to ensure that there are no
false negatives. We do this every month for quality control.
XPERT MTB/RIF
RNTCP has approved of Xpert MTB/RIF but is still
debating about their operational feasibility—whether
to place them at district level, or at microscopy
centres, or at state level. At one time this machine
can process only 4 samples in 2 hours. So in one day
we can process a maximum of 16 samples. In LPA we
can process 40-50 samples in a two days cycle.
We do liquid culture here also which takes 2 Bio Safety Level II (BSL-2)
to 3 weeks.” laboratories do not have
Dr Vidyanidhi: negative pressure. But for the
“Bio Safety Level II (BSL-2) laboratories do sample preparation, sample
not have negative pressure. But for the procedure, and extraction of
sample preparation, sample procedure, and DNA, the environment requires
extraction of DNA, the environment requires
negative pressure which is available in BSL-3 negative pressure which is
laboratory. We have to have strict infection available in BSL-3 laboratory.
control so as not to contaminate the sample. We have to have strict
We have a dedicated material transport infection control so as not to
vehicle. The samples are put on it and our contaminate the sample
technical staff transports them to the
receiving window outside. As per the Bio-
Safety Level Laboratory Guidelines, the sample and the reagents have to move in one
direction only, through power flow in that particular closed chamber. So the infection
is also controlled. The environment is cleaned through ultraviolet (UV) rays.”
BSL-3
In the changing room, we wear all personal protection (PP) equipment (such as a new
N95 mask, shoe protection, a special apron, goggles in some cases, etc) in sequential
order. We have to check the mask compatibility and integrity too. No air should come
in from the sides of the mask to ensure that it is properly placed on the face. There
should be no leakage.
We can use one N95 mask for a maximum of 8 hours. Normally we work for 4 hours in
the laboratory in one day and so we can use the same mask for two days. One N95
mask costs around INR 400 (USD 8) in the open market but we get it at a lower price.
There is a special interlocking device for opening and closing of entrance door of the
BSL-3 laboratory. We can also check the number of people who have been in the
laboratory earlier. We have to maintain optimum temperature and pressure. If we
want to open one door, we have to close the other door first. If we open both doors
at the same time, then negative pressure will get dis-balanced. That is why we have
As per the guidelines, every nook and corner of the BSL-3 laboratory is regularly
fumigated with water and formaldehyde.
Once the sample is decontaminated and processed it is then segregated and brought
to the other 2 biosafety cabinets—one part goes for LPA (after DNA extraction) and
the other for liquid culture. We have liquid culture facility where we use the machine
referred to as Becton Dickinson (BD)’s MGIT.
XPERT MTB/RIF
We have the Xpert MTB/RIF but it is still under PMDT’s
evaluation so it is not being used for testing routine patient
samples. We have done our own evaluation process and are
currently using the machine for research purposes as of
now.”
LIQUID CULTURE
We use liquid culture to test for sensitivity to four drugs: Rifampicin, Isoniazid,
Streptomycin and Ethambutol. Either we can do liquid culture after LPA results or we
can do both tests together alongside each other.
SOLID CULTURE
Solid culture is still our golden
standard and perhaps we may never
be able to replace it with any other
modern technique at least in the
present context. In solid culture we
are able to differentiate between
the colony morphology, colour and
pigmentation of the bacteria, but in
liquid culture we are not able to
differentiate between all these
parameters.
Mr Rajnarayan, microbiologist:
“We are using home-made media for
solid culture for DST. We make our
media for solid culture and also
have negative pressure facility for
inoculation. Our laboratory
Right now we are doing DST using solid culture for first line drugs. For rifampicin we
are using 1% proportional method (For Rifampicin we are taking 40 microgram per ml
and for isoniazid 29 microgram per ml).
We send the test reports through email and/or SMS to the respective DTOs.”
Dr Dang’s Lab
Dr Navin Dang:
“We are very particular about the
quality of reagent. The quality of
reagent and sample is important for
getting good results. This is the major
thing that lacks in most of the
laboratories. We calibrate our cold
rooms once every 2-3 months. Quality
control team maintains the temperature
of the cold rooms daily. The
temperature inside the room is below
zero. We have a protocol for keeping the
samples for some period. We keep the
samples stored here as they might be
required for some repeat tests or for some
other test in near future.
MICROSCOPY
All samples are routinely tested through microscopy apart from other advanced tests.
It has to be validated by doctors and only then it is authenticated. Every sputum
sample goes through pathologists’ eyes before it gets validated. Every sample has to
be stained. The slides are numbered properly thereafter. The system automatically
reads the sample barcode-wise.
TREATMENT PROCEDURE
Ideally it should take at least 2 weeks to put an MDR-TB patient on Cat- 4 treatment
once the sputum sample is collected and sent for tests. When a patient from say any
area of Delhi is diagnosed with MDR-TB, he/she then goes to the nearest DOTS clinic
and from there is sent to the respective chest clinic. The DTO at the chest clinic fills
an RNTCP form called Annexure 5 and sends the patient to our PMDT site with the
form and culture report. Now we have to pre-evaluate the patient before starting
treatment to rule out other medical conditions if any, like HIV, thyroid (as MDR-TB
drugs cause hypo-thyroidism as a possible side-effect), and diabetes among others.
We also do ECG and chest X-Ray of the patient. All these investigations are done free
of cost. We have to take the patient’s consent for starting treatment.
After doing pre-evaluation of the patients we prepare a PMDT Treatment Card and
send the patients to Rajan Babu Institute of Pulmonary Medicine and TB (RBIPMT) for
treatment initiation. There they are admitted for a minimum of 7 days to check if
they can tolerate the drugs and do not have adverse drug reactions (1%-2% patients
are not able to tolerate kanamycin injection reactions). Then the patient is
discharged with 7 days medicine for transit
period and RBIPMT sends us an email too. After We also have a regimen
receiving the email, we inform that particular for the migrant
chest clinic to arrange for the patient’s population. We provide
medication.
them with a postcard.
If any problem occurs with the patient during So they go and give it to
follow up —culture is positive again -- then the nearest DOTS site
he/she is sent by the MO for culture test here.
The MO or a doctor here fills up the Annexure 2 and thus we come to
referral form. When the sputum report comes know that the person is
from the AIIMS laboratory an email is sent from registered there as the
the laboratory itself to the chest clinic whether
the patient is positive or negative. If found postcard is sent to the
positive the laboratory sends another filled form STO. If the post card is
to us and we pre-evaluate the patient. After not received then the
pre-evaluation we send the patient to RBIPMT,
and also inform them by email that a patient tracing for the patient
has been sent. After three days we find out starts at the earliest
We also have a regimen for the migrant population. We provide them with a postcard.
So they go and give it to the nearest DOTS site and thus we come to know that the
person is registered there as the postcard is sent to the STO. If the post card is not
received then the tracing for the patient starts at the earliest.
Nutritional diet plays a key role in combating MDR-TB and also ensuring treatment
adherence. It is important for TB patients to eat good nutrition in order to develop
strong immunity to fight the disease and tolerate the toxic side-effects of medicines.
The history of most of our TB patients (including those from upper strata) shows that
they are poor eaters and do not take a proper diet at proper time. We find that there
is greater problem of Extra Pulmonary TB (EPTB) in urban population. Even after a lot
of motivation, some of the patients tend to run away from treatment due to the long
course and side-effects of medicines. Tracing patients who leave the treatment in
between is a big problem,
especially in case of migrants.” Smoking and alcoholism are two main
Dr Shalini (in the MDR-TB clinic):
problems likely to be in men which often
“Smoking and alcoholism are two affect their treatment adherence.
main problems likely to be in men Women are likely to adhere better to
which often affect their treatment but they suffer more because
treatment adherence. Women are
likely to adhere better to
of the unhygienic conditions in which
they are likely to be living, especially in
rural areas where hygiene is not paid
much attention
Best Practices in PMDT in India | July 2013
76
treatment but they suffer more because of the
unhygienic conditions in which they are likely to The other problem that
be living, especially in rural areas where hygiene women face, especially in
is not paid much attention. Some of our EPTB
female patients from rural areas do not pay
rural areas and urban slums,
attention to basic hygiene. So this could be a is that they stay indoors for
factor, though we do not have any data on it. The most of the time within
other problem that women face, especially in
rural areas and urban slums, is that they stay poorly ventilated houses
indoors for most of the time within poorly with a lot of cook stove
ventilated houses with a lot of cook stove smoke
pollution, whereas men do go out in fresh air and smoke pollution, whereas
spend less time in cramped homes. Women hide men do go out in fresh air
their problems too and the husbands have no
time to inquire about the spouses’ health.
and spend less time in
cramped homes. Women
The patients must be provided with some hide their problems too and
nutritional/monetary support, especially those
who are daily wage earners. Patient education the husbands have no time
and awareness is also very important.” to inquire about the
spouses’ health
We treat all patients free of cost, so there is an eligibility criterion for them to
become eligible for seeking treatment here. Before putting a patient on treatment,
we do house visit of the patient, and if we find that they really cannot afford their
own treatment then only we put them on treatment.
Patients referred from KS Roy Hospital do not come here every day for their
medicines but take it from the hospital only as we provide the medicines every 2 to 4
weeks to this hospital.
As per guidelines we have annexures 1 and 2 in the referral form. If the patient has
some adverse drug problem then he/she is sent here with same referral form. We fast
track the patients in the OPD—if they come with annexure 1 we know it is for pre-
treatment evaluation of MDR-TB. We do LFT, RFT, thyroid function test, blood
investigations, X-Ray. Then after 2 days we start Cat-4 treatment. We observe the
patient for 3-4 days. If patient is not facing any problems we discharge him/her with
some documents like PMDT Treatment Card for the patient, Discharge Card for
hospital, and i-card among others. We telephonically inform the district centre to
which the patient is going so that his/her treatment begins upon reaching there.
But now we are decentralizing the system and starting this pre-treatment evaluation
at district level also. Many patients were finding it inconvenient to come to our
centre for treatment initiation. Also, many
investigations can be done at district level Gujarat developed the model for
itself and very few cases require making patient-wise monthly drug
hospitalization. The practice now is that the boxes. Now this model has been
patient gets all pre-treatment investigations
approved in 2012 by CTD to be
done at district level itself and then the
scanned copy of the results is sent to the DR- used throughout the country. The
TB committee. A committee is also formed at reason for one month boxes is
the district level comprising the civil that all MDR-TB drugs are
superintendent and physicians. So we can temperature (<25 degrees Celsius)
interact with them either through phone or and humidity (<60%) sensitive.
email. Thus patients who hesitate to come
However, efficacy of drugs is
here can seek treatment in their own district
under the supervision of the district staff. maintained for a period of 6
months even if they are exposed
PMDT DRUG BOXES to sunlight and humid conditions.
We prepare one month drug boxes for the MDR- We wanted to ensure that they
TB patients. Such type of arrangement was remain under ideal conditions as
piloted for the first time in Gujarat. Gujarat far as possible. So at the state
developed the model for making patient-wise
level we have the state-of-art
boxes. Now this model has been approved in
2012 by CTD to be used throughout the drug store (at BJMC) with
country. The reason for one month boxes is temperature and humidity
that all MDR-TB drugs are temperature (<25 controls. We have also upgraded
degrees Celsius) and humidity (<60%) sensitive. all the 30 district centres with AC
and humidity control monitors.
Best Practices in PMDT in India | July 2013
79
However, efficacy of drugs is maintained
for a period of 6 months even if they are
exposed to sunlight and humid conditions.
We wanted to ensure that they remain
under ideal conditions as far as possible. So
at the state level we have the state-of-art
drug store (at BJMC) with temperature and
humidity controls. We have also upgraded
all the 30 district centres with AC and
humidity control monitors. But we do not
have these optimal drug storage facilities at
the peripheral level of PHCs and sub
centres. So from the district level, only 1
month boxes are issued to the DOTS
providers at peripheral level. So storage
becomes easier. We have designed special
14 grooved boxes (patient of highest weight
band requires 14 tablets). This can be used
even by uneducated peripheral DOTS
providers, who just have to give one tablet
from each of the compartments—there is no
need to count the appropriate number of
tablets to be given for that particular
weight band.
Initially there was a problem for women to come under the purview of MDR-TB
treatment for fear of rejection by their families. But now once they are diagnosed
with MDR-TB we counsel the families to take care of the patient. If they refuse to do
so then we provide food to them along with the drugs. So now the problem is being
gradually overcome.”
We found that out of the 30% patient we lose (patients with presumptive MDR-TB who
were not put on MDR-TB treatment) about 8%-9% patients died during those three
months, because they were presumed to have MDR-TB but were not put on treatment
as they were waiting for diagnostic reports.
Another set of 8%-9% patients lost faith, because they knew they were not responding
to the treatment and we were giving them the same treatment during the time taken
to confirm the diagnosis and start MDR-TB treatment. So they went away to the
private sector to get treatment. Some of the patients were also lost to follow up as
we were not able to hold them back. In many places like Delhi there is a big
population of migrants who might have gone back to their native places.
Regarding treatment, we give free drugs. As for infrastructure, we already have DOTS
centres. The only thing is that we have to augment and train our DOTS providers
regarding MDR-TB treatment (which is prolonged and the drugs are toxic).
Another challenge was that initially we were getting low treatment success rates of
about 50%-60% in PMDT because perhaps patients were opting out of treatment due to
severe side-effects of the toxic second line drugs. Now, we are training our DOTS
We have designed a very simple questionnaire for our DOTS providers. They ask the
patients whether they have got itching, swelling in the body, vomiting or other side-
effects. If there is, we immediately refer the patient to the doctor for management
of side-effects and encourage the patient to continue treatment.”
One new thing that we have started here is the follow up—once a patient is started on
treatment and sent back to his/her place there are different checks and balances. I
give a phone call to the respective district TB centre that we have received your
We also ask the patients to bring their relatives to this centre to get tested. The
programme also says that sputum samples of contacts of MDR-TB patients should be
sent for testing. We have had 20 families with more than one MDR-TB patient. In one
family there was a young patient (who died eventually of XDR-TB) who first took
treatment in private sector. Then his brother, sister and both parents also got MDR-
TB. His brother is admitted here and sister is also on treatment. We need to make
The patient will develop resistance if treated with only one drug. If we can control
basic TB at the start with a proper therapy no resistance would develop. Even today
more than 91 combinations of medicines are used in the private sector which is a big
problem as it simply multiplies the resistance in the community.”
Taking care of the adverse side effects of medicines plays a very big
role in restoring patients’ confidence and ensuring treatment
adherence. We have found that over 40% patients have joint pains,
20% have nausea and vomiting, 15% suffer from anxiety. Besides
these, there are numerous other side effects, including weakness
A pain in chest…
Dinesh works as a cook in Delhi. His family comprising his mother, wife, one son and
two daughters live in his native village in Almora—a hilly region in North India. About
a year ago, (around May 2012) he complained of pain in his chest. He showed himself
in AIIMS and was diagnosed with TB. He was put on Cat 1 treatment under DOTS. But
when the sputum report was positive even after 5 months, the doctors suspected drug
resistance. Dinesh was lucky to be in Delhi and luckier to be seeking treatment from
AIIMS- a tertiary care hospital with very good diagnostic facilities. The Line Probe
Assay confirmed resistance to isoniazid and he was immediately put on MDR-TB
treatment regimen in October 2012.
When I met him in February 2013 in the OPD of AIIMS, he had completed almost 5
months of medication from the DOTS plus site of AIIMS. His one report had already
come negative and the next one was to come in a week’s time. Of late Dinesh had
“Three years ago, in 2010, I started having persistent low grade fever and cough.
There was never enough money in the house, so I took treatment intermittently in the
private sector, as and when I had money. But one and a half years ago my condition
worsened. I was breathless all the time and could not even walk properly. So I
eventually came to this government hospital (BJ Medical College) where I was
admitted for 3 months for TB treatment but was eventually diagnosed with MDR-TB.
My family is very supportive despite the infectious nature of the disease. My husband
always accompanies me to the hospital.”
Unfortunately, Rukmini’s daughter contracted MDR-TB through her mother and has
been on MDR-TB treatment in the same hospital since the last 6 months. The
Rakesh had been on MDR-TB treatment (Cat 4) for the past one year. Narrating his
story, Rakesh spoke with bitterness about his bad experiences with the private set up
while seeking treatment. He was also critical about the social stigma connected with
the disease that led to delay in his seeking proper diagnosis and treatment of MDR-TB
in a good government hospital.
Three years ago, in 2010, his persistent cough led Rakesh to a private TB physician
who put him on ATT. His cough vanished after six months of treatment and he felt fit
and fine again. But his state of wellbeing was short lived. After 6-7 months he started
coughing again. This time he went to a PHC close to his village.
“The health worker there asked me to bring some people from my village who would
give the guarantee that I would complete a 6 months’ treatment course. I did that
and took medicines religiously for 4 months. But instead of improving, my condition
worsened. My father and I begged the healthcare workers at the PHC to please test
me again and send my sputum for culture. But they insisted on my completing the 6
months course first. In desperation I left that treatment and again went to the same
private doctor from whom I had taken treatment earlier. I took medicines for another
one and a half year, including injections, spending INR 6000 per month on my
treatment. Yet there was no improvement in my condition. My doctor said that now
the cost of medicines will increase to 15,000 per month. Although I had no money
problem but this was really beyond my pocket. He was kind enough to give me the
address of Dr RN Solanki, PMDT Nodal Office, BJMC, Ahmedabad, Gujarat, and so I
came to this hospital for the first time in February 2012. I stayed in the hospital for 3
days and then went back to my village. Earlier also I had been on Cat-4 treatment in
the private. This time I was given 11 medicines
and one injection per day. I did not suffer any He spoke with bitterness
side-effects and continued with the medicines. about his bad experiences
After 6 months I had to go to Rajasthan for
some work. It was very hot there and one day I with the private set up
vomited blood. I had carried my medicines and while seeking treatment.
my medical file with me. I showed myself to He was also critical about
the government doctor there and he advised
me to take rest. I came back to my village and the social stigma
took complete rest for two months but again I connected with the
vomited blood. This was repeated again after disease that led to delay
a few months. I had not missed a single dose
of medicine but my health had broken down in his seeking proper
completely.” diagnosis and treatment
of MDR-TB in a good
According to Dr Purvi the swelling in his legs
was due to some adverse drug reaction and government hospital
also due to some other co-morbid condition
“My father and brother were very reluctant to bring me to this hospital for a checkup,
despite the doctor at the PHC asking them to do so. They are uneducated and think
that if a case is referred to this big hospital, it means it is a gone case. They think
that only very serious patients who are on death bed (with no hope of cure) are
advised to go to a tertiary hospital like this. They feared that I was being referred
here as I was about to die. They finally agreed because of my insistence and so I came
here today with my brother and my wife. I love my wife and my 5 year old son. She is
not educated but takes very good care of me.”
He joked that his beautiful and chubby wife cannot get TB as she is fat, but if she
were thin she might be at risk.
His message to other TB patients: People in the villages still think that TB is incurable
and is a death sentence. They also feel that government hospitals are no good. Even I
used to think that as treatment in private sector is expensive so it ought to be better
than that in a government hospital. This ignorance must be removed. We must face
the disease bravely and not be afraid or get dejected. If you are scared you will die, if
you are brave you will survive.
(Rakesh told me that this was the first time he had dared to narrate all this to a complete
stranger like me, with a view to share his story with others as he did not want anyone else to
suffer the same fate as he did out of ignorance and fear).
Adhering to
treatment,
but lost
hearing power
irreparably…
I met 19 year old Reena at the
MDR-TB drug dispensing counter
of RB TB hospital, New Delhi,
where she had come to take her
daily dose of MDR-TB medication.
Her hearing power had been
Reena said, “I am now feeling much better. Earlier I was not able to walk properly
and I lost a lot of hair—I almost turned bald. Now I just have hearing problem
otherwise I am okay. My two married sisters died of TB, but I want to live and lead a
normal TB free life. I love to watch old movies and eat meat, fish and eggs. I would go
back to my studies once I am okay.”
In 2010, when Anil was 30 years old, he suffered from persistent cough. He sought
treatment from a private doctor who diagnosed TB and put him on an 8 month long
course of ATT. He spent INR 70,000 (approximately USD 1400) on his medication but
was presumably cured. He stayed well for the next two years. Then one day in 2012
Anil religiously follows the doctor’s advice on all the precautions he has been asked to
take. He has got all his family members tested for TB and fortunately none of them
have the disease. At home he always spits in a cup of hot water and disposes off his
sputum by burying it in mud. He thinks that non vegetarian diet is more nutritious, so
he has started eating meat and eggs for more nourishment. But this he has to do
outside his house as his family is strictly vegetarian.
Anil has now become a TB advocate in his own way and guides patients to a
government facility for diagnosis and treatment.
His message for other TB patients: Please do not waste money on costly and
improper treatment in the private sector. A government hospital is the best place
where the problem will not only be diagnosed completely but a proper and lasting
solution (treatment) will also be provided by the doctors.
Ajay’s message: I would like to spread the message that government is taking a lot of
initiative for TB care and control. But very often the money provided for this work is
not used properly, especially in a state like UP which has been riddled with corruption
scams. The media should also pay some more attention to this problem and spread
awareness in common public. If I stay alive I will become an advocate for TB control
and spread awareness about it in society.
Deserted by
his family,
divorced by
wife, PMDT
staffers
become his
new family…
Anirban Mukherjee is from
Kolkata. An only child, he is
32 years old and educated
till Class 10. He was already
married and had a daughter
when he was first diagnosed My sputum which was sent to DMC for
with TB in 2002. At that time testing (while I was working in
he was working as a marketing
manager in the mess of a
Dhanbad) came out positive again at
students’ hostel in Dhanbad. the end of 2011. So in 2012 I was back
He first took treatment in the in the same hospital with XDR-TB
private sector but then came
Meanwhile his wife had divorced him in 2008 because of his TB and taken her away
her daughter with her. His employer turned him out of his job and his landlord threw
him out of his house. His mother too refused to take him back. He was now homeless
and a destitute. So he returned to the same hospital and the Superintendent at KS
Roy Hospital admitted him on compassionate grounds. He has been there at this
centre since then—for over 1 year and 2 months. The sister in charge of the MDR-TB
ward told that he would remain here as long as his treatment continues.
No one else in his family has ever had TB. He never smoked nor ate gutkha/paan
masala but used to take alcohol occasionally.
Now his own people have left him. Abandoned by family, it is strangers who are taking
care of him and attending on him. Yet there was a glow of happiness and gratitude on
Anirban’s face. He said, “I am very happy staying in the ward here. The sisters
(nurses) are doing much more than my family could ever have done. They are very
dedicated in their work. All the responsibilities which should have been taken by my
family members are being done by the sisters the care givers and doctors of this
hospital. They are helping me in whatever way they can. They are closest to my
heart. I am too happy to stay in the hospital. I have no feelings for my real family, but
I am very grateful to all the hospital staff.”
(The sister-in-charge said that Abdul was diagnosed with MDR-TB last year in 2012.
He was sent here recently and is now on CAT 4 treatment).
Abdul admitted to being a smoker but then he left smoking three years ago, when he
got married, at the insistence of his wife. He said that he was very happy with the
His message to other TB patients: All patients should practice infection control
methods and use masks. This I tell my family members also and ask them to keep
away from me. My parents are not following strict infection control protocol at
home. But I always use a mask and cover my mouth when I am coughing. Please pray
for my recovery.
She fell ill around 20th August 2012 with severe cough. She was shown to a private
doctor and her treatment started on 29th August. She ate the medicines for whatever
period of time they were prescribed. (Neither she nor her mother were able to recall
the exact duration of the
treatment). She had to take
over 80 injections as well. To
make matters worse, her liver
was also affected and she got
an attack of jaundice. She
continued with the same
doctor but her condition did
not improve. She would feel
nauseas and vomit all the
time. Eventually the doctor
said that as the medicines
were not improving her
condition, she should be taken
to a government hospital. Her
parents, in the absence of any
proper knowledge about TB,
took her to a government
facility in Baratalla where her sputum tested negative. From there they were directed
to Aamtala hospital where the sputum test result was positive for MDR-TB. She was
then sent to K S Roy Hospital in Jadavpur.
I wished Rehana good luck and told her that she should go back to studies once she is
cured, and look after herself well and eat well. That brought a smile to her pale face
and she promised to do so.
Neelam’s problems began in January 2012 when she had a slight cough
accompanied with a persistent high fever. The doctor at PG Hospital
No one else in Neelam’s family, including her two younger brothers, has ever suffered
from TB. But all of them, including her college friends have been very cooperative
and stood by her side during her illness. Neelam’s mother, however, who was
attending on her, complained that, “Neelam is a poor eater and that could be the
Neelam told me that she loves to read and study. Even earlier, while on treatment,
she managed to appear for her exams despite high fever. She is determined to pursue
her post-graduation once she is cured.
(The nurse in the ward said that for some unknown reasons the incidence of TB is
very high in the PG Quarters area which she called a den of tuberculosis.)
Krishna’s message to other TB patients: Cure for this disease is possible. However one
needs to have patience, and although one might face many problems in the beginning
by way of side effects of medicines, but in the end all will be fine. Slowly the patient
recovers from the disease if he or she takes proper and continuous medication as
prescribed. So one must have patience and take medicines regularly.
Mukesh said that, “I faced a lot of difficulties due to severe side effects of medicines.
My whole body would feel as if on fire; there was severe body pain and I would feel
Mukesh’s message to other TB patients: Never miss any dose of drug and take the
medicines properly if you want to get cured.
(Calcutta Rescue Centre has a tie up with KS Roy Hospital. They have 2 staff
members who visit K S Roy Hospital every Friday and cater to all the patients of
Calcutta Rescue Centre admitted there and also provide medicines to some other
patients admitted there—those who are outside the DOTS plus programme).
Now I am feeling much better and I walk to this centre alone every day after
attending school to take my medicines. I had to discontinue my studies because of my
The doctor has asked me to take some preventive measures at home which I follow
religiously-- I have my separate bed at home; I have separate utensils to eat my food
and a separate water bottle. I do not eat with my siblings. Even in school I keep a
handkerchief on my mouth while talking or sneezing.
Nusrat’s message to other TB patients: I want to tell all other people that they must
take proper medicines and on time and should never miss even a single dose. They
should adhere to their treatment and complete it and not leave it in between.
When I spoke to Nusrat in February 2013, she sounded very optimistic and full of
hope. Going back to school had perhaps worked wonders for her mental health. She
was happy to be with her friends once again and no longer treated as an outcast.
There was no trace of dejection and depression in her talks. In fact she promised to
meet me on her next visit to her grandparents’ house in Amethi.
Bhaskar had the usual symptoms of cough and fever in 2012 when he went to a private
doctor who diagnosed him with TB on the basis of a chest X-Ray. The doctor said that
it would take him 8-9 months to get cured. So Bhaskar did not take his disease
seriously and started his medication under his doctor. He never thought it necessary
to go to a government centre. But even after completing 6 months of treatment
there was no visible improvement in his condition. Alarmed at this he showed himself
at this hospital where he was diagnosed with MDR-TB. He had been on MDR-TB
treatment at Lok Nayak Hospital since April 2012.
Bhaskar has faced lot many problems during the course of his treatment. Earlier he
suffered from excessive weight loss and faced other problems too like stomach ache,
vomiting, and nausea. When I met him he sounded very dejected, especially because
of the toxic side effects of medicines. He lamented, “If there is something which I
cannot just digest is why these 2 painful years of medicines—were the medicines not
good enough? Right now also I am suffering from many side effects of medicines. I feel
very restless at night after taking my medicines. I feel okay in the latter part of the
day, but I cannot sleep properly at night, and next morning I have to go to my job. So
it becomes very tiring for me, although I am a bit relaxed than before. Earlier, when
I was taking painful injections, it was worse. Whatever anyone told me to do in the
last 2 years I have done that. I only hope that now I will get better.”
“I am taking all precautions as told by the doctors here. I have been told to use a
separate room and toilet. In the initial period I used to wear a mask but not now. As
much as I can I take all precautions. I am ready to do things that are required at the
moment even if by little force as I really want to get cured.”
“I do not know if smoking was responsible for my TB. If everyone stops smoking then
India will become the poorest country of the world due to loss of revenue. But
anyways, I have quit smoking and it is okay with me. And I am not tempted to take to
He probably contracted TB
probably 3 years ago in 2010
when he was studying at Nadwa
College in Lucknow. It started
with cold and cough. He showed
himself in a government hospital
in Lucknow and was diagnosed
with TB. So he went back home
and began his treatment in some government hospital in Haryana. But as he was not
getting well he thought the treatment did not suit him, and he left it midway without
completing the 6 month regimen. He then turned to a private doctor and was under
his treatment for 2 years, spending INR 3000 per month on his medicines. But he was
not getting any better. As he was now living in Delhi, he eventually showed himself at
Lok Nayak Hospital where he was diagnosed with MDR-TB. His medication for MDR-TB
began on 26th September, 2012 and when I met him in February 2013 he was in the
fifth month of his treatment.
Rafiq said that, “I am feeling much better with the treatment provided here, although
after taking injections and medicines I do feel restless at times. This centre opens at
9 am, so I come here to take the medicines and injections and then go to college, as
my classes start from 10 am. I have taken a room here in Delhi and stay alone. I do
not cook my own food but eat in a hotel as I have to take proper diet to bear the side
effects of drugs. I do not take anything like cigarettes or alcohol. The doctor here has
not asked me to eat anything in particular, but people have advised me to eat more
non vegetarian food as it gives more energy. No other person in my family has TB and
none of them have been tested for this disease. I have mostly stayed away from
home, so it is unlikely that they will get the infection from me.”
In the MDR-TB OPD of Lok Nayak TB Hospital I came across the harried father of a 19
years old girl who had reached Delhi that very morning of February, 2013 and then
had immediately come to the hospital. His daughter’s case had been referred from
SGPGI Lucknow to this hospital.
His heart rending tale of woes was a living testimony of a callous and irresponsible
private sector and a careless government sector. He was carrying a fat load of her
past prescriptions gathered as the hapless father went from one doctor to another;
from one treatment to another; while her TB got worse by the day.
The duo belonged to MP where the girl first took ill in September 2010. She had
constant fever and cough. Her sputum was tested and X-Ray was also taken. She took
treatment under a private doctor for 8 months. She was okay for 4 months and then
the problems recurred. This time the father took her to a government hospital in
Chhatarpur where she was again put on a 9 months regimen. But the medicines had to
For the last three months she had had no fever or cough and for the first time after
2010 she was feeling better. But probably the right treatment came to her a bit too
late-- one of her lungs had been damaged almost completely and she was also
suffering from a total loss of appetite. So she had been referred to this hospital.
(The attending doctor in the OPD went through all her past prescriptions very
rigorously and concluded that she although she had been given kanamycin
earlier by the doctor in MP, but other second line drugs were not given. So she
developed resistance. The SGPGI doctors followed the protocol. Their tests
revealed MDR-TB and they treated her accordingly. But they were not able to
get the desired response. So now they doubted that she is resistant to second
line drugs also—which means that it could be a case of XDR-TB. The doctor also
said that as per the rules, if XDR-TB is diagnosed, this hospital would not be
able to provide free drugs to this outstation patient, although they would give
other support. Drugs from the private market would cost around INR 5 lakhs,
for the whole course of treatment. However, he said that they we would try to
register her under some project or the other which go on in RB TB Hospital and
LRS Hospital, and if she is lucky she would get free treatment under them. But
there was no guarantee of this).
Brother of the patient –“Initially we spent a lot of money (over INR two lakhs) on
private doctors’ treatment in Darbhanga, Bihar, with no positive outcomes. Then
some people of the village told us about this LRS Institute and so we brought him here
as already a person from our own village had taken treatment here and got well. Saral
has now been on treatment at LRS Institute for the past one and a half years and
since the time he is taking treatment he is feeling much better. The patient had
started working also as he felt better. But then again his condition started worsening
and so he was admitted here a few days ago. The doctor has said that they have now
replaced the old drugs with more powerful ones. He is facing some problems in
urination and so he will remain here for another 2-3 days and would be relieved after
that and the medicine would continue till the doctor says. By God’s grace all is going
well now. Now he has the confidence that he will get well soon but had he known
about this place earlier then treatment would have started early too. In the villages,
those persons who know even a little about TB, apply their own knowledge and ask to
shift the patient to so or so place.”
The brother and mother of Saral were all praises for the doctors and the staff who are
very efficient and nice. They said that he was just a bag of bones when he came to
this hospital and now his health has improved because of the good care that he has
been given.
The advice of patient’s brother to other people: it is important to meet the right
doctor and contact qualified persons for seeking proper treatment. They should not
listen to every person who has some advice to offer. Instead they should apply their
own sense, otherwise nothing other than simple time waste would come in hand.
The nurse informed that perhaps the family is not realizing that XDR-TB is very
difficult to treat. Of course right now they are very happy that since they brought
the patient here, he has improved tremendously.
Rinki was put on TB treatment in 2009 when she was 14 years old. She completed 6
months therapy at LRS Institute and then tested negative. She remained okay for 6
months. Meanwhile she was married off by her parents (despite being so young and
recuperating from a debilitating disease). But after some time her problem of cough
and fever recurred and she was ill again. This time she was put on a 10 month
treatment course. But her in-laws did not pay much attention and there was
carelessness in taking medicines regularly. This disruption in treatment further
deteriorated her condition. She was admitted in LRS Institute for 4 months, and then
she became better and was discharged. After 1 month she was sick again. This whole
cycle repeated once again. She was eventually diagnosed with MDR-TB one and half
years ago. Since then she has been on MDR-TB treatment for the last 18 months. Now
she is negative and in the continuation phase of treatment. But her lungs are
damaged, so she needs an oxygen cylinder to breathe.
When she is out of the hospital she needs a cylinder which costs 300 per day which
her poor parents can ill afford. So she just keeps flitting in and out of the hospital
where mercifully she is able to get free admittance. But the hospital administration
Rinki repeatedly told me that she felt very guilty for putting her parents to so much
of trouble because of her seemingly never ending illness. No one else has TB in her
family. Her father has resigned himself to his fate. He said that, “Perhaps taking TB
medicine is like spraying insecticide in the body. If any germ remains, TB recurs—else
why did my daughter get it over and over again?”
The Sister-in-charge of the ward said that although Rinki had become negative, but as
soon as she goes home after getting discharged she starts facing problems of oxygen
shortage and then she returns as they are too poor to afford an oxygen cylinder
continuously. Her condition will improve gradually but for that she regularly needs
nutritious and protein rich diet and fresh fruits which the family is perhaps unable to
afford. Once her MDR-TB medication is over she would be prescribed some lung
exercises to improve her lung condition.
The latest CT study of my chest reveals multiple nodules, many of them calcified, and
also fibroatelectatic lesions in both lung fields. The appearance is consistent with
chronic tubercular lesions. Compared with previous CT chest studies of 2010 and
2011, there is relative regression of the lung parenchymal lesions. CT study of head
reveals an enhancement in right cavernous sinus as well as right convexity. In view of
the size of lesion and my age (33years), radiosurgery-- cyber knife—has been
suggested by doctors at Medanta Medicity Hospital.
My father’s sudden demise in 2010 has left me and my mother in a penniless situation,
and my younger brother is now the sole earning member of the family. We are left
with nothing to carry on my treatment. We are homeless, being evicted by landlords
as and when they feel I am contagious because of my TB. At present I am living in a
crummy rented place with narrow stairs, without ventilation, which is having adverse
effects on my lung lesions, bone TB and hypoxia related VHL tumours which are
growing fast. Initial support was provided by my friends and well-wishers but they and
my brother can no longer pull the economy of my diseases together.”
Note: Presently as of 1 May 2013, she is struggling to raise resources enough to meet
her healthcare financial expenses for a range of conditions.
Munawwar’s ordeal began in 2006 when he was diagnosed with TB for the first time.
“At that time I used to eat gutkha, smoke cigarettes and bidi. Firstly I showed myself
in the Ahmedabad Municipality TB Centre but my condition did not improve. I was also
not very regular with my treatment and would go on and off medicines. In 2008 I
sought treatment in the private sector, but my condition deteriorated. But God is
great. He came to me in the garb of Leuva Sahib (who had treated me earlier). Dr
Leuva stopped me one day while I was driving my auto rickshaw and asked me to
meet him in the hospital as he wanted to talk to me. I felt very happy and proud that
such a reputed doctor had called me personally. So I went to him and he gave me the
confidence that I will be cured of my TB. My medicines for MDR-TB started in October
2009. On Dr Leuva’s insistence I gave up smoking bidi, cigarette, and eating gutkha,
and started taking my medicines religiously. I had to stay in the hospital for 19 days. I
had to take 13 tablets every day. I always ate them together in one go and also took
injections for 6 months. While on treatment I once fractured my leg and was admitted
to a nearby hospital for about 4 months. During that time Leuva sahib would come
personally to give me injections. So my treatment was not disrupted.”
“Now I have been completely cured since 2011. I owe all my good health to Dr Leuva.
It is only because of him that I am standing perfectly well on my feet today along with
Explained Dr Leuva, “Munawwar had been a Cat 1 treatment failure earlier and hence
a presumptive MDR-TB patient. I was there in the same government hospital where
Munawwar had sought treatment earlier and I knew he had been defaulting on
treatment. At that time there was no government programme to treat MDR-TB. So he
had shifted to the private sector and was on kanamycin under the private doctors.
When government programme for MDR-TB treatment started in Gujarat, I
remembered him and thought to bring him to the government clinic so that he could
get free treatment. I knew that he sometimes came to this particular spot. So I would
stand there every day waiting for him as I did not have his home address. I finally
found him one day, and asked him to come to the hospital. Initially he did not want to
take the treatment as he had no faith in the government programme. Moreover it
took 4 months for the test report to come and confirm the diagnosis of MDR-TB. Even
after the diagnosis it took a lot of effort to make him agree to begin treatment. While
on treatment he once fractured his leg and was confined to bed. I ensured to give him
his daily dose of injections during this period by doing home visits as a special case.
Today he is standing in front of you—fit and fine.”
Munawwar has since become a TB advocate and his mission is to spread awareness
about TB in the general population. I found his auto rickshaw decorated with several
hoardings with informative messages on TB and advertisements about the government
TB programme. Now whenever Munnawar sees any patient suffering from TB then he
goes to the patient and tells him/ her that once he also had the same problem and
now he is doing well after taking treatment. He always keeps the hospital card in his
pocket to show others how he got well and from where he took his treatment. He has
brought many patients to the programme who had either left treatment midway or
were hesitant to begin treatment.
“If I find any person suffering from TB, I try to share their suffering and problem and
bring them free of cost in my auto to this DOTS centre. This is the only way I can show
my gratitude for all that Leuva sahib did for me. I have brought many patients here.
Sometimes the patient gets angry on me but I do not mind it as deep inside my heart I
“If I find any person suffering from TB, I try to share their
suffering and problem and bring them free of cost in my auto to
this DOTS centre. This is the only way I can show my gratitude for
all that Leuva sahib did for me. I have brought many patients
here. Sometimes the patient gets angry on me but I do not mind it
as deep inside my heart I know how painful the whole process is.
My work is only to make them understand because a person gets
irritated while on treatment as I have gone through all this myself
Dr Nevin Wilson, Regional Director of the South-East Asia Office, International Union
Against Tuberculosis And Lung Disease (The Union), rightly believes that, “Patients
and communities are central to TB control. Patients must be empowered to act
positively for their own good through full knowledge of their illness and the risks
involved in not completing treatment. They also require support to complete a full
course of treatment. This support has to be continuous and includes the regular
provision of medication; counselling to understand the side effects of medication and
the need to persist with complete treatment.”
Seeing is believing, and, coming across a grateful patient advocate and a devoted (yet
very humble) doctor, restored my faith in our combined ability to control the menace
of all forms of TB—sensitive and resistant. There are many more such healthcare
professionals and advocates doing inspiring work in our midst. We just need to help
them multiply their efforts, in whatever way we can, to fulfill our mission of a TB free
world.
The Charter sets out the ways in which patients, communities, health-care providers, both
private and public, and governments can work together as partners in a positive and open
relationship, to improve standards of TB care and enhance the effectiveness of the health-
care process. It allows all parties to be held more accountable to each other, fostering
mutual interaction and a “positive partnership”.
Developed in tandem with the International Standards for Tuberculosis Care (1) to promote a
“patient-centred” approach, the Charter adheres to the principles on health and human rights
of the United Nations, UNESCO, WHO and the Council of Europe, as well as other local and
national charters and conventions (2).
The Charter embodies the principle of Greater Involvement of People with TB (GIPT). This
affirms that the empowerment of people with the disease is the catalyst for effective
collaboration with health-care providers and authorities and is essential to victory in the fight
to stop TB. The Charter, the first global “patient-powered” standard for care, is a
cooperative tool, forged from a common cause, for the entire TB community.
PATIENTS’ RIGHTS
1. CARE
a. The right to free and equitable access to TB care, from diagnosis to completion of
treatment, regardless of resources, race, gender, age, language, legal status, religious
beliefs, sexual orientation, culture or health status.
b. The right to receive medical advice and treatment that fully meets the new
International Standards for Tuberculosis Care, centring on patient needs, including
those of patients with MDR-TB or TB-HIV co-infection, and preventive treatment for
young children and others considered to be at high risk.
c. The right to benefit from proactive health sector community outreach, education
and prevention campaigns as part of comprehensive health-care programmes.
2. DIGNITY
a. The right to be treated with respect and dignity, including the delivery of services,
without stigma, prejudice or discrimination by health-care providers and authorities.
b. The right to high-quality health care in a dignifi ed environment, with moral support
from family, friends and the community.
3. INFORMATION
a. The right to information about the availability of health-care services for TB, and
the responsibilities, engagements and direct or indirect costs involved.
c. The right to know the names and dosages of any medications or interventions to be
prescribed, its normal actions and potential side-effects and its possible impact on
other conditions or treatments.
d. The right of access to medical information relating to the patient’s condition and
treatment and to a copy of the medical records if requested by the patient or a person
authorized by the patient.
e. The right to meet, share experiences with peers and other patients and to voluntary
counselling at any time from diagnosis to completion of treatment.
4. CHOICE
a. The right to a second medical opinion, with access to past medical records.
c. The right to choose whether or not to take part in research programmes without
compromising care.
5. CONFIDENCE
a. The right to respect for personal privacy, dignity, religious beliefs and culture.
6. JUSTICE
a. The right to make a complaint through channels provided for this purpose by the
health authority and to have any complaint dealt with promptly and fairly.
b. The right to appeal to a higher authority if the above is not respected and to be
informed in writing of the outcome.
7. ORGANIZATION
a. The right to join, or to establish, organizations of people with or affected by TB,
and to seek support for the development of these clubs and community-based
associations through health-care providers, authorities and civil society.
8. SECURITY
PATIENTS’ RESPONSIBILITIES
1. Share information
a. The responsibility to provide as much information as possible to health-care
providers about present health, past illnesses, any allergies and any other relevant
details.
2. Follow treatment
a. The responsibility to follow the prescribed and agreed treatment regimen and to
conscientiously comply with the instructions given to protect the patient’s health and
that of others.
b. The responsibility to show consideration for the rights of other patients and health-
care providers, understanding that this is the dignified basis and respectful foundation
of the TB community.
4. Solidarity
a. The moral responsibility to show solidarity with other patients, marching together
towards cure.
c. The moral responsibility to join in efforts to make the community free of TB.
Help turn these words into realities. Support the drive towards implementation in the
community.
Source: Patients’ Charter for Tuberculosis Care © 2006 World Care Council
WARDS
Key Recommendations:
Located away from the other wards, with adequate facilities for hand washing and
good maintenance and cleaning.
Adequate ventilation (natural and/or assisted ventilated) to ensure >12 Air Changes
per Hour (ACH) at all times.
Adequate space between 2 adjacent beds, at least 6 feet
Cough hygiene should be promoted through signage and practice ensured through
patients and staff training, ongoing reinforcement by staff
Adequate sputum disposal, with individual container with lid, containing 5% phenol,
for collection of sputum
All staff should be trained on standard precautions, airborne infection control
precautions, and the proper use of personal respiratory protection. A selection of
different sizes of re-usable N95 particulate respirators should be made available for
optional use by staff.
It is crucial that patients with Rifampicin resistance be referred for treatment as soon as
possible. If Rifampicin resistance – with or without INH resistance – is confirmed, the DTO will
trace the patient, with help of the Medical Officer – TB control (MO-TC) and Senior
Treatment Supervisor (STS) and bring them to the DTC where they will be counselled by the
DTO. Counselling should include (1) information on the lab results, and the reliability of lab
results from RNTCP certified C-DST laboratories, (2) the need for additional treatment, (3)
the importance of rapid initiation of treatment, (4) the services RNTCP offers for PMDT, (5)
what patients should do next, and (6) infection control precautions that are necessary, and
reassurance to the family against panic or unnecessary stigmatization of the patient. After
counselling, the patient is referred to the concerned DR-TB Centre with their DST result and
PMDT referral for treatment form
All MDR-TB cases will be offered referral for HIV counselling and testing at the nearest centre
if the HIV status is not known or the HIV test is found negative with results more than 6
months old
It is advisable to involve close family members during the counselling, since family support is
an essential component in the management. Patients should be advised to report any side
effects experienced by them. Female patients should receive special counselling on family
planning.
A patient is confirmed to have MDR or XDR TB only when the results are from a RNTCP quality-assured Culture &
DST Laboratory and by a RNTCP-endorsed testing method.
It is to be noted that rifampicin resistance is quite rare without isoniazid resistance. The great majority of DST results
with rifampicin resistance will also be isoniazid resistance, i.e. MDR TB. Therefore RNTCP has taken the programmatic
decision that patients who have any Rifampicin resistance, should also be managed as if they are an MDR-TB case, even
if they do not formally qualify as an MDR-TB case as per the above definition. Therefore programme and clinical actions
will be driven primarily by rifampicin DST results.
Conventional DST evaluates if M. tuberculosis grows in the presence of drug-containing media, and is also known as
phenotypic DST. Molecular DST evaluates for the presence of genetic mutations that are highly associated with
phenotypic resistance, and is also known as genotypic DST.
The differences between the tests should be understood. Phenotypic DST is available for more drugs, and is considered
very reliable for isoniazid (H), rifampicin (R), and streptomycin (S), and somewhat less reliable for other drugs such as
ethambutol (E).
Molecular/genotypic DST is highly reliable for rifampicin, but has limited sensitivity for detection of isoniazid resistance.
Results from any RNTCP-approved tests are considered equivalent, and can be the basis of clinical action, though in
some settings additional testing will be done.
Molecular/genotypic tests are much faster than phenotypic tests, as molecular tests don’t require growth of the
organism, and M. tuberculosis is notoriously slow growing. The turnaround time for C-DST results by Solid LJ media is
around 84 days, by Liquid Culture (MGIT) is around 42 days, by LPA is around 72 hours and by CB-NAAT is around 2 hours.
Best Practices in PMDT in India | July 2013
135
DST for Ofloxacin (O) and Kanamycin (Km) and Pyrazinamide (Z) will be introduced and gradually scaled up to all RNTCP-
certified C-DST Laboratory in the near future.
MDR DIAGNOSTIC TECHNOLOGY CHOICE
1. Molecular DST (e.g. LPA DST)
2. Liquid culture isolation and LPA DST
3. Solid culture isolation and LPA DST
4. Liquid culture isolation and Liquid DST
5. Solid culture isolation and Solid DST
SPECIMEN COLLECTION
An often-overlooked problem is that of obtaining adequate good quality specimens at the peripheral laboratories. Unless
specimens are collected with care and promptly transported to the laboratory under temperature control, diagnosis may
be missed, and the patient could miss the chance to be detected and put on the correct treatment. A good sputum
specimen may literally make the difference between life and death, and allow containment of the disease and prevent
spread to others in the family and community.
The Laboratory technician needs to explain the process of collecting “a good quality sputum specimen” and avoid using
vernacular terminologies that convey the meaning as saliva instead of sputum. In addition though the general guideline
for collection of sputa is one spot and one morning, this does not preclude from collecting 2 spot specimens that need to
be collected with a gap of at least one hour (60 minutes) if the patient is coming from a long distance or there is a
likelihood that the patient may default to give a second specimen.
A good sputum specimen consists of recently discharged material from the bronchial tree, with minimum amounts of
oral or nasopharyngeal material. Satisfactory quality implies the presence of mucoid or mucopurulent material. Ideally,
a sputum specimen should have a volume of 3-5ml. The patient must be advised to collect the specimen in a sterile
container (falcon tube) after through rinsing of the oral cavity with clean water.
Specimens should be transported to the laboratory as soon as possible after collection. If delay is unavoidable, the
specimens should be refrigerated up to 1 week to inhibit the growth of unwanted micro-organisms.
The following points are critical for the collection of fresh sputum samples at DMCs:
- The falcon tubes and the 3 layer packing materials like thermocol box, ice gel pack (prefreezed at -20 degree for 48
hours), request for C-DST forms, polythene bags, tissue paper roll as absorbent, parafilm tapes, brown tape for
packaging box, permanent marker pen, labels, bio-hazard sticker, scissors, spirit swab etc. should be supplied to the
DMCs for collection of sputum through the DTO.
- The falcon tubes should carry a label indicating the date of collection of the samples and the patient’s details like
name, date of sample collection, name of DMC/DTC, Lab. No:- XYZ, specimen A or B
- The Lab technicians (LT) at DMCs should be trained to carefully pack the sputum samples in the cold box to avoid
spillage of the samples.
- The LT of DMC issuing the falcon tubes to the patients should also give clear instructions to the patients on correct
technique of collection of the sputum. Also the date of issue of the falcon tubes to the patient should be recorded.
- The LT of the DMC should ensure that the request for C-DST form is packed in a separate plastic zip pouch and placed
in the cold box before sealing the lid of the box. Also, the biohazard symbol should be pasted on the external side of the
cold box along with the label indicating the postal address of the RNTCP-certified C-DST Lab assigned.
- The LT of the DMC should promptly inform the sample transport agency like a courier / speed post service, speed post
or a human carrier to collect and transport the samples
Best Practices in PMDT in India | July 2013
136
As per the national guidelines for Biomedical waste management the containers used for transporting sputum samples to
the RNTCP-certified laboratory should be labelled with a “BIO-HAZARD” sticker.
Source: Guidelines for PMDT in India: May 2012
A patient who is a presumptive case of MDR-TB, should be referred by the respective medical officer –
peripheral health institute (MO-PHI) to the nearby DMC that has been developed for sample collection for C-
DST at the earliest i.e. as soon as the sputum results are available. If the diagnosis is based on Line Probe
Assay (LPA), the patient’s results will be available within 48 hours and the decision of starting the patient on
the appropriate regimen can be taken after results are available.
PRE-TREATMENT EVALUATION
The patient should be hospitalised (at the DR-TB Centre) for pre-treatment evaluation and treatment
initiation. Pre-treatment evaluation should include a thorough clinical evaluation by a physician, chest
radiograph, and relevant haematological and bio-chemical tests. Since the drugs used for the treatment of
MDR-TB are known to produce adverse effects, a proper pre-treatment evaluation is essential to identify
patients who are at increased risk of developing such adverse effects. A thorough clinical examination should
be done during the pre-treatment evaluation. The pre-treatment evaluation will include the following:
1. Detailed history (including screening for mental illness, drug/alcohol abuse etc.)
2. Weight
3. Height
4. Complete Blood Count with platelets count
5. Blood sugar to screen for Diabetes Mellitus
6. Liver Function Tests
7. Blood Urea and S. Creatinine to assess the Kidney function
8. TSH levels to assess the thyroid function
9. Urine examination – Routine and Microscopic
10. Pregnancy test (for all women in the child bearing age group)
11. Chest X-Ray
All MDR-TB cases will be offered referral for HIV counselling and testing.
INDOOR ADMISSION
The patient will be admitted in the designated DR-TB Centre in-door facility for at least seven days post-treatment
initiation. This period of admission will allow for
investigations to be undertaken;
The hospital should provide comfortable living conditions, adequate food, proper ventilation and sufficient activities to
keep the patients occupied. Further admission may be necessary during ambulatory treatment for management of
severe adverse drug reactions, complications, to assess need and fitness for surgical intervention; social reasons, etc.
After admission at the DR-TB Centre for at least seven days post-treatment initiation, the patient can be discharged to
the residence district with up to a maximum of one week’s supply of drugs, arrangements for injections in transit, and a
copy of the treatment card and referral form. The respective DTO should be informed by the attending physician of the
patient’s planned discharge 3 days prior to the actual date of discharge, by means of the RNTCP PMDT referral for
treatment form which can be sent by email.
Standardised treatment outcome definitions are to be used following treatment of an MDR-TB case. These
definitions apply to patients with rifampicin resistance (who are taken to be MDR-TB for management
purposes), and XDR-TB cases as well:
: A patient who has completed treatment and has been consistently culture negative (with at
least 5 consecutive negative results in the last 12 to 15 months). If one follow-up positive culture is
reported during the last three quarters, patient will still be considered cured provided this positive
culture is followed by at least 3 consecutive negative cultures, taken at least 30 days apart, provided
that there is clinical evidence of improvement.
: Treatment will be considered to have failed if two or more of the five cultures
recorded in the final 12-15 months are positive, or if any of the final three cultures are positive.